Challenges of cognitive research in neurofibromatosis type 1

Authors

Maria T. Acosta, George Washington UniversityFollow

Document Type

Letter to the Editor

Publication Date

11-2013

Journal

Lancet Neurology

Volume

Volume 12, Issue 11

Inclusive Pages

1040-1041

Keywords

Child Behavior Disorders--drug therapy; Cognition Disorders--drug therapy; Hydroxymethylglutaryl-CoA Reductase Inhibitors--pharmacology; Neurofibromatosis 1--drug therapy; Simvastatin--pharmacology

Comments

Comment on:

Simvastatin for cognitive deficits and behavioural problems in patients with neurofibromatosis type 1 (NF1-SIMCODA): a randomised, placebo-controlled trial. [Lancet Neurol. 2013]

APA Citation

Acosta, M. T. (2013). Challenges of cognitive research in neurofibromatosis type 1. The Lancet Neurology, 12(11), 1040-1041.

Peer Reviewed

1